Pricing Log in Create free account

Charles River Laboratories International, Inc. (CRL) vs Medpace Holdings, Inc. (MEDP)

Charles River Laboratories International, Inc. and Medpace Holdings, Inc. are both Diagnostics & Research companies. Medpace Holdings, Inc. is the larger, with a market value of $17.8B against $14.9B — 1.2× the size. Medpace Holdings, Inc. trades at the lower P/E: 34.6× against 300×. Medpace Holdings, Inc. grew revenue faster over the last twelve months: 20.4% against −1.16%. Medpace Holdings, Inc. has the higher net margin (18.2% vs 1.01%) and the lower return on invested capital (0.00% vs 1.81%). Across the 22 metrics below, Medpace Holdings, Inc. leads on 17 and Charles River Laboratories International, Inc. on 5.

Valuation

Metric CRL MEDP Diagnostics & Research median
P/E 300.09 34.57 34.52
P/S 3.77 6.25 4.24
P/B 4.64 30.31 3.42
Price to free cash flow 37.56 26.56 33.51
EV/EBITDA 31.20 27.01 23.44
EV/Sales 4.34 6.04 5.18
Earnings yield 0.33% 2.89% (1.50%)
Free cash flow yield 2.66% 3.77% 0.00%

Profitability

Metric CRL MEDP Diagnostics & Research median
Gross margin 33.33% 72.24% 48.32%
Operating margin 4.00% 21.39% (5.68%)
Net margin 1.01% 18.24% (4.10%)
Free cash flow margin 10.05% 23.52% 0.00%
Return on equity 1.21% 117.88% 0.00%
Return on assets 0.54% 25.54% (6.05%)
Return on invested capital 1.81% 0.00% 0.00%

Growth

Metric CRL MEDP Diagnostics & Research median
Revenue growth (TTM) (1.16%) 20.35% 8.99%
EPS growth (last fiscal year) (1,555.00%) 20.98% 20.36%
Revenue growth, 5-year CAGR 6.55% 22.27% 7.30%
Net income growth, 5-year CAGR 0.00% 25.50% 0.00%

Health

Metric CRL MEDP Diagnostics & Research median
Debt to equity 0.76 0.00 0.01
Current ratio 1.41 0.83 2.27
Net debt to EBITDA 3.24 (0.88) 0.68

Dividend

Metric CRL MEDP Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric CRL MEDP Diagnostics & Research median
Market cap 14.94b 17.76b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack